Liquid biopsies provide a minimally invasive approach for tumour molecular profiling, through the detection and analysis of various analytes (circulating ... with several liquid biopsy-based ...

Dr. Marla Lipsyc-Sharf reviews her recent session at the 2024 SABCS meeting, discussing biopsy approaches and treatment ...

Liquid biopsy is a revolutionary molecular diagnostic tool that allows scientists to detect genetic abnormalities or monitor disease progression non-invasively. However, clinicians encounter several ...

Luis E. Raez, MD, discusses the current liquid biopsy options for patients with lung cancer through assessing circulating tumor DNA. Luis E. Raez, MD, medical director and chief scientific officer at ...

An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9, according to research presented at the American ...

Recently, FVU has garnered research interest as a critical component in cancer diagnostic test development, particularly in the liquid biopsy field.

Dual analysis of these liquid biopsy analytes enables longitudinal monitoring of patients throughout clinical trials and may enable early identification of non-responders and identify patients ...

Payers want to make sure patients are getting biopsies done so they can get on the right therapies, said Bhuvana Sagar, MD, Oncology Consultants.

The firm presented early data for a blood-based approach to screen prostate cancer patients for PSMA, which it believes has ...

Liquid biopsy refers to the analysis of bodily fluids, most commonly blood, to detect tumor-derived analytes such as circulating tumor cells (CTCs) or ctDNA. The detection of ctDNA has shown great ...

PanGIA Biotech–a pioneer in liquid biopsy technology–today announced its first international partnership, collaborating with Canary Oncoceutics (Canar ...